Crossref
Zilebesiran Add-On Treatment for Inadequately Controlled Hypertension—Reply
JAMA · 04.11.2025 · 334 (17) · 1559
DOI: 10.1001/jama.2025.13329 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAMA, erschienen am 04.11.2025. Verfasst von Akshay Desai und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, Massachusetts. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 3 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
- Alnylam Pharmaceuticals, Cambridge, Massachusetts.
- Barts Health NHS Trust, Queen Mary University of London, London, United Kingdom.
Zitieren
APA
Desai, A., Havasi, A., & Saxena, M. (2025). Zilebesiran Add-On Treatment for Inadequately Controlled Hypertension—Reply. JAMA, 334(17), 1559. https://doi.org/10.1001/jama.2025.13329
Vancouver
Desai A, Havasi A, Saxena M. Zilebesiran Add-On Treatment for Inadequately Controlled Hypertension—Reply. JAMA. 2025;334(17):1559. doi:10.1001/jama.2025.13329
BibTeX
@article{Desai2025,
author = {Desai, Akshay and Havasi, Andrea and Saxena, Manish},
title = {Zilebesiran Add-On Treatment for Inadequately Controlled Hypertension—Reply},
journal = {JAMA},
year = {2025},
volume = {334},
number = {17},
pages = {1559},
doi = {10.1001/jama.2025.13329}
}
EUVIMED